Microfluidic assessment of metastatic potential

A microfluidic assay that quantifies the abundance and degree of proliferation of migratory cells predicts the metastatic potential of breast-cancer cell lines and patient-derived cells.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Microfluidic assay for the prediction of the metastatic potential of breast-cancer cells.

Change history

  • 23 July 2019

    An amendment to this paper has been published and can be accessed via a link at the top of the paper.


  1. 1.

    Siegel, R. L., Miller, K. D. & Jemal, A. CA Cancer J. Clin. 69, 7–34 (2019).

  2. 2.

    Nguyen, D. X., Bos, P. D. & Massague, J. Nat. Rev. Cancer 9, 274–284 (2009).

  3. 3.

    Bettegowda, C. et al. Sci. Transl. Med. 6, 224ra224 (2014).

  4. 4.

    Yankaskas, C. et al. Nat. Biomed. Eng. https://doi.org/10.1038/s41551-019-0400-9 (2019).

Download references

Author information

Correspondence to Roger D. Kamm.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark